ESMO Asia 2022 | Unmet needs in immunotherapy for hepatocellular carcinoma

Mara Persano, MD, University Of Cagliari, Cagliari, Italy, discusses the current unmet needs in the field of immunotherapy (IO) for patients with hepatocellular carcinoma (HCC). These include investigation of IO-based combination therapies and identification of which subgroups of patients will benefit most from IO. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.